TRLS-02. SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)

Authors: Macarena de la Fuente, Nicholas A Butowski, Jennie Taylor, Rona Yaeger, Frank Y-C Tsai, Filip Janku, Carl E Allen, Natraj Ammakkanavar, Glenn Michelson, Ping Jiang, Emil Samara, Michael Paz, Alexia Tussay-Lindenberg, Kongming Wang, Stacie P Shepherd, Irina Kline, Eric Sherman, Jordi Rodon

Published: 2024-06-18

DOI: 10.1093/neuonc/noae064.155

Source: Full article

TRLS-02. SAFETY AND EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394; PLX8394) IN CHILDREN AND ADULTS WITH RECURRENT, BRAF-ALTERED PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)

Abstract